1. Home
  2. OPEN vs GRFS Comparison

OPEN vs GRFS Comparison

Compare OPEN & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opendoor Technologies Inc

OPEN

Opendoor Technologies Inc

HOLD

Current Price

$4.85

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.47

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPEN
GRFS
Founded
2014
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.4B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
OPEN
GRFS
Price
$4.85
$7.47
Analyst Decision
Sell
Hold
Analyst Count
3
2
Target Price
$1.67
$10.15
AVG Volume (30 Days)
32.7M
595.1K
Earning Date
05-07-2026
07-28-2022
Dividend Yield
N/A
1.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,371,000,000.00
N/A
Revenue This Year
$3.04
$4.49
Revenue Next Year
$53.82
$6.42
P/E Ratio
N/A
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$7.39
52 Week High
$10.87
$11.14

Technical Indicators

Market Signals
Indicator
OPEN
GRFS
Relative Strength Index (RSI) 48.48 35.66
Support Level $4.74 $7.44
Resistance Level $5.01 $8.88
Average True Range (ATR) 0.34 0.17
MACD 0.07 -0.03
Stochastic Oscillator 45.30 3.70

Price Performance

Historical Comparison
OPEN
GRFS

About OPEN Opendoor Technologies Inc

Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital-light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: